1887
Preview this article:
Zoom in
Zoomout

serovar Typhi strain producing extended-spectrum β-lactamases in Dhaka, Bangladesh, Page 1 of 1

| /docserver/preview/fulltext/jmm/61/7/1032_jmm044065-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.044065-0
2012-07-01
2019-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/7/1032.html?itemId=/content/journal/jmm/10.1099/jmm.0.044065-0&mimeType=html&fmt=ahah

References

  1. Ahmed D., D’Costa L. T., Alam K., Nair G. B., Hossain M. A.. ( 2006;). Multidrug-resistant Salmonella enterica serovar Typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh. . Antimicrob Agents Chemother 50:, 3516–3517. [CrossRef][PubMed]
    [Google Scholar]
  2. Al Naiemi N., Zwart B., Rijnsburger M. C., Roosendaal R., Debets-Ossenkopp Y. J., Mulder J. A., Fijen C. A., Maten W., Vandenbroucke-Grauls C. M., Savelkoul P. H.. ( 2008;). Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. . J Clin Microbiol 46:, 2794–2795. [CrossRef][PubMed]
    [Google Scholar]
  3. Baraniak A., Sadowy E., Hryniewicz W., Gniadkowski M.. ( 2002;). Two different extended-spectrum β-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland. . J Clin Microbiol 40:, 1095–1097. [CrossRef][PubMed]
    [Google Scholar]
  4. Bavdekar S. B.. ( 1996;). Antimicrobial therapy of multidrug resistant typhoid fever in children: pediatricians’ opinion. . J Postgrad Med 42:, 65–67.[PubMed]
    [Google Scholar]
  5. Cantón R., Novais A., Valverde A., Machado E., Peixe L., Baquero F., Coque T. M.. ( 2008;). Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. . Clin Microbiol Infect 14: (Suppl. 1), 144–153. [CrossRef][PubMed]
    [Google Scholar]
  6. CLSI ( 2008;). Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement. M100-S18. . Wayne, PA:: Clinical and Laboratory Standards Institute;.
  7. Crump J. A., Luby S. P., Mintz E. D.. ( 2004;). The global burden of typhoid fever. . Bull World Health Organ 82:, 346–353.[PubMed]
    [Google Scholar]
  8. Edelstein M., Pimkin M., Palagin I., Edelstein I., Stratchounski L.. ( 2003;). Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. . Antimicrob Agents Chemother 47:, 3724–3732. [CrossRef][PubMed]
    [Google Scholar]
  9. Gniadkowski M.. ( 2001;). Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. . Clin Microbiol Infect 7:, 597–608. [CrossRef][PubMed]
    [Google Scholar]
  10. Lal P., Kapil A., Das B. K., Sood S.. ( 2007;). Occurrence of TEM & SHV gene in extended spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. . Indian J Med Res 125:, 173–178.[PubMed]
    [Google Scholar]
  11. Livermore D. M., Brown D. F.. ( 2001;). Detection of β-lactamase-mediated resistance. . J Antimicrob Chemother 48: (Suppl. 1), 59–64. [CrossRef][PubMed]
    [Google Scholar]
  12. Pardos de la Gándara M., Seral C., Castillo García J., Rubio Calvo C., Weill F. X.. ( 2011;). Prevalence and characterization of extended-spectrum beta-lactamases-producing Salmonella enterica isolates in Saragossa, Spain (2001–2008). . Microb Drug Resist 17:, 207–213. [CrossRef][PubMed]
    [Google Scholar]
  13. Pokharel B. M., Koirala J., Dahal R. K., Mishra S. K., Khadga P. K., Tuladhar N. R.. ( 2006;). Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. . Int J Infect Dis 10:, 434–438. [CrossRef][PubMed]
    [Google Scholar]
  14. Saha S. K., Talukder S. Y., Islam M., Saha S.. ( 1999;). A highly ceftriaxone-resistant Salmonella Typhi in Bangladesh. . Pediatr Infect Dis J 18:, 387. [CrossRef][PubMed]
    [Google Scholar]
  15. Stephen J. M., Toleman M. A., Walsh T. R., Jones R. N.. ( 2003;). Salmonella bloodstream infections: report from the SENTRY Antimicrobial Surveillance Program (1997–2001). . Int J Antimicrob Agents 22:, 395–405. [CrossRef][PubMed]
    [Google Scholar]
  16. Threlfall E. J.. ( 2002;). Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. . FEMS Microbiol Rev 26:, 141–148. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.044065-0
Loading
/content/journal/jmm/10.1099/jmm.0.044065-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error